Cdx2 as a Marker for Neuroendocrine Tumors of Unknown Primary Sites

MLA

Ricardo V. Lloyd, et al. “Cdx2 as a Marker for Neuroendocrine Tumors of Unknown Primary Sites.” Endocrine Pathology, vol. 15, Jan. 2004, pp. 247–52. EBSCOhost, https://doi.org/10.1385/ep:15:3:247.

APA

Ricardo V. Lloyd, Nobuki Nakamura, Bettina G. Papouchado, Shuya Zhang, Haytham H. Dimashkieh, & Lori A. Erickson. (2004). Cdx2 as a Marker for Neuroendocrine Tumors of Unknown Primary Sites. Endocrine Pathology, 15, 247–252. https://doi.org/10.1385/ep:15:3:247

Chicago

Ricardo V. Lloyd, Nobuki Nakamura, Bettina G. Papouchado, Shuya Zhang, Haytham H. Dimashkieh, and Lori A. Erickson. 2004. “Cdx2 as a Marker for Neuroendocrine Tumors of Unknown Primary Sites.” Endocrine Pathology 15 (January): 247–52. doi:10.1385/ep:15:3:247.